We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$252M
AUM Growth
-$86.3M
Cap. Flow
-$109M
Cap. Flow %
-43.42%
Top 10 Hldgs %
38.06%
Holding
113
New
35
Increased
12
Reduced
16
Closed
45

Top Buys

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$11M
2
LH icon
Labcorp
LH
+$9.27M
3
MRK icon
Merck
MRK
+$8.29M
4
LIVN icon
LivaNova
LIVN
+$7.92M
5
ATHN
Athenahealth, Inc.
ATHN
+$5.37M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$10.7M
2
BCR
CR Bard Inc.
BCR
+$9.32M
3
GSK icon
GSK
GSK
+$8.25M
4
UNH icon
UnitedHealth
UNH
+$7.79M
5
CNC icon
Centene
CNC
+$7.73M

Sector Composition

Rank Sector Weight
1 Healthcare 65.96%
2 Industrials 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEN icon
26
Penumbra
PEN
$12.8B
$4.39M 1.74%
50,000
-12,555
-20% -$1.07M
TSRO
27
DELISTED
TESARO, Inc.
TSRO
$4.18M 1.66%
+29,900
New +$4.33M
NUVA
28
CALL
DELISTED
NuVasive, Inc.
NUVA
$3.85M 1.53%
+50,000
New +$3.74M
EW icon
29
CALL
Edwards Lifesciences
EW
$51.7B
$3.55M 1.41%
+90,000
New +$3.29M
GILD icon
30
Gilead Sciences
GILD
$165B
$3.54M 1.41%
+50,000
New +$3.33M
SUPN icon
31
Supernus Pharmaceuticals
SUPN
$2.77B
$3.45M 1.37%
80,000
-92,500
-54% -$3.29M
ABBV icon
32
AbbVie
ABBV
$435B
$3.34M 1.32%
46,012
-36,613
-44% -$2.46M
AXGN icon
33
Axogen
AXGN
$2.5B
$3M 1.19%
179,369
+129,669
+261% +$1.75M
CLVS
34
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$2.81M 1.12%
+30,000
New +$1.84M
WMGI
35
CALL
DELISTED
Wright Medical Group Inc
WMGI
$2.75M 1.09%
+100,000
New +$2.83M
BRKR icon
36
Bruker
BRKR
$8.14B
$2.35M 0.93%
+81,617
New +$2.1M
IMMU
37
DELISTED
Immunomedics Inc
IMMU
$2.27M 0.9%
256,800
-288,200
-53% -$2.02M
ARRY
38
DELISTED
Array Biopharma Inc
ARRY
$2.22M 0.88%
265,589
+42,589
+19% +$348K
NDRM
39
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$2.09M 0.83%
70,000
-33,850
-33% -$877K
TSRO
40
CALL
DELISTED
TESARO, Inc.
TSRO
$1.83M 0.73%
+13,100
New +$1.9M
OTIC
41
DELISTED
Otonomy, Inc.
OTIC
$1.82M 0.72%
96,800
-40,700
-30% -$568K
HZNP
42
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.78M 0.71%
+150,000
New +$1.87M
VRAY
43
DELISTED
ViewRay, Inc.
VRAY
$1.69M 0.67%
+260,670
New +$1.75M
EPZM
44
DELISTED
Epizyme, Inc
EPZM
$1.51M 0.6%
+100,000
New +$1.51M
VIVE
45
DELISTED
VIVEVE MED INC
VIVE
$1.44M 0.57%
200
+6
+3% +$44.7K
ADMS
46
DELISTED
Adamas Pharmaceuticals
ADMS
$1.38M 0.55%
79,103
-158,397
-67% -$2.62M
STDY
47
DELISTED
SteadyMed Ltd
STDY
$1.36M 0.54%
215,214
+135,780
+171% +$923K
SGYP
48
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.19M 0.47%
267,800
+67,800
+34% +$280K
SVRA icon
49
Savara
SVRA
$1.19B
$1.18M 0.47%
+200,000
New +$1.37M
CDTX
50
DELISTED
Cidara Therapeutics
CDTX
$1.13M 0.45%
+7,500
New +$1.04M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q2 2017 Portfolio in Review

As of Q2 2017, Pura Vida Investments held 113 positions worth $252M, down 26% from $338M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $109M in Q2 2017, closing 45 positions and reducing 16 holdings. Its most notable exit was Hologic, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 74% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Express Scripts Holding Company worth $11.2M.

  • Pura Vida Investments's largest Q2 2017 buy was Express Scripts Holding Company: 174,700 shares worth $11.2M.
  • Pura Vida Investments added most to NanoString Technologies, Inc. in Q2 2017, an estimated $4.51M increase.
  • Pura Vida Investments's biggest Q2 2017 reduction was Exact Sciences, cutting an estimated $6.94M.
  • Pura Vida Investments fully exited Hologic in Q2 2017, selling an estimated $10.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $252M portfolio in Q2 2017.
  • Pura Vida Investments opened 35 new positions and closed 45 in Q2 2017.
  • Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $252M.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.